Bristol-Myers Squibb (BMY) – Credit Ratings
-
Bristol-Myers Squibb's (BMY) 'Disappointing' Opdivo Data in NSCLC has No Impact on Ratings - Moody's
-
Fitch Raises Outlook on Bristol-Myers Squibb (BMY) to Stable; Notes Firm Leverage Level, Pipeline Progression
-
Fitch Lowers Outlook on Bristol-Myers Squibb (BMY) to Negtative; Affirms Ratings
-
Moody's Revises Outlook on Bristol-Myers Squibb (BMY) to Negative
-
Fitch Downgrades Bristol-Myers' (BMY) IDR from 'A' to 'A-'; Outlook Revised to Stable
Back to BMY Stock Lookup
